25,749 Shares in CME Group Inc. (NASDAQ:CME) Bought by Cinctive Capital Management LP

Cinctive Capital Management LP purchased a new stake in shares of CME Group Inc. (NASDAQ:CME) in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 25,749 shares of the financial services provider’s stock, valued at approximately $5,682,000.

Several other institutional investors have also added to or reduced their stakes in the company. Truvestments Capital LLC purchased a new stake in shares of CME Group during the third quarter worth about $26,000. Y.D. More Investments Ltd purchased a new stake in CME Group in the 2nd quarter worth approximately $36,000. McClarren Financial Advisors Inc. grew its position in shares of CME Group by 66.1% in the 2nd quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock worth $39,000 after buying an additional 78 shares during the last quarter. Asset Dedication LLC increased its stake in shares of CME Group by 515.2% during the second quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock valued at $40,000 after buying an additional 170 shares during the period. Finally, Thurston Springer Miller Herd & Titak Inc. increased its stake in shares of CME Group by 62.2% during the third quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock valued at $43,000 after buying an additional 74 shares during the period. Hedge funds and other institutional investors own 87.75% of the company’s stock.

CME Group Stock Up 0.3 %

CME opened at $238.00 on Monday. The stock has a market capitalization of $85.77 billion, a price-to-earnings ratio of 25.03, a PEG ratio of 5.49 and a beta of 0.55. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09. The firm has a 50 day moving average price of $225.55 and a 200-day moving average price of $211.96. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $238.97.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, topping the consensus estimate of $2.65 by $0.03. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The company had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.59 billion. During the same quarter in the previous year, the company posted $2.25 earnings per share. CME Group’s revenue was up 18.4% compared to the same quarter last year. Equities research analysts forecast that CME Group Inc. will post 10.22 earnings per share for the current year.

CME Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Monday, December 9th will be paid a $1.15 dividend. This represents a $4.60 annualized dividend and a dividend yield of 1.93%. The ex-dividend date is Monday, December 9th. CME Group’s dividend payout ratio (DPR) is presently 48.37%.

Insider Buying and Selling

In other CME Group news, insider Timothy Francis Mccourt sold 1,374 shares of the company’s stock in a transaction dated Monday, October 28th. The stock was sold at an average price of $227.12, for a total value of $312,062.88. Following the completion of the sale, the insider now owns 7,275 shares in the company, valued at $1,652,298. This represents a 15.89 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Timothy S. Bitsberger sold 1,000 shares of CME Group stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $226.96, for a total transaction of $226,960.00. Following the transaction, the director now directly owns 10,589 shares in the company, valued at $2,403,279.44. This represents a 8.63 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 8,028 shares of company stock valued at $1,811,681. 0.30% of the stock is owned by insiders.

Analysts Set New Price Targets

Several analysts recently weighed in on the stock. Piper Sandler lifted their price target on shares of CME Group from $240.00 to $250.00 and gave the company an “overweight” rating in a report on Monday, October 28th. Morgan Stanley boosted their price target on shares of CME Group from $210.00 to $233.00 and gave the company an “equal weight” rating in a research report on Thursday, October 17th. Royal Bank of Canada reissued a “sector perform” rating and issued a $235.00 price target on shares of CME Group in a research note on Thursday, October 24th. Barclays lifted their price objective on CME Group from $219.00 to $231.00 and gave the company an “equal weight” rating in a research report on Thursday, October 24th. Finally, Oppenheimer increased their target price on CME Group from $245.00 to $258.00 and gave the stock an “outperform” rating in a research report on Thursday, October 24th. Four research analysts have rated the stock with a sell rating, seven have given a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, CME Group currently has an average rating of “Hold” and an average price target of $224.47.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.